Sudha Chakrapani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sudha Chakrapani has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Sandip Basak
School of Biological Sciences, Nanyang Technological University, Singapore, Republic of Singapore
9 shared publications - Eduardo Perozo
Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, USA
8 shared publications - Arvind Kumar
Thermo Fisher Scientific
6 shared publications Eric Gibbs
Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106-4970, USA
5 shared publications- Julio F. Cordero-Morales
Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, Houston, USA
5 shared publications Yvonne Gicheru
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, 44106-4970, USA
5 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by Wiley in British Journal of Pharmacology
Structural characterisation of the effect of 5‐chloroindole on orthosteric activation of murine 5‐HT 3A receptors
Background and Purpose: 5‐HT 3 receptors play a central role in gut–brain signalling, and their hyperactivity is associated with pathologies ranging from chemotherapy‐induced nausea and vomiting to irritable bowel syndrome. While the principles governing 5‐HT 3 R orthosteric pharmacology are well established (spanning antagonists, partial agonists and full agonists), structural insights into allosteric mechanisms remain limited. This study aimed to investigate the mechanisms by which a positive modulator of 5‐HT 3 R, 5‐chloroindole, potentiates agonist response by fine‐tuning orthosteric activation of this receptor. Experimental Approach: Here, we investigated the molecular basis of modulation by 5‐chloroindole (5‐CI), a selective positive allosteric modulator, using cryo‐EM and electrophysiology. We present 5‐HT 3A R structures in the presence of 5‐CI alone, as well as in combination with either submaximal concentrations of 5‐HT or saturating concentrations of the partial agonist SMP‐100. Key Results: Our results reveal that 5‐CI potentiates 5‐HT 3 R through a distinct mechanism involving co‐occupancy of the orthosteric site and with additional modulation through an intersubunit site in the transmembrane domain. Conclusions and Implications: This mode of action is reminiscent of benzodiazepine modulation in GABA A Rs, yet it notably occurs within homomeric binding sites. Together, these findings establish the structural basis for the previously reported ago‐allosteric mechanism of 5‐CI, which becomes functionally apparent only in the presence of agonistic ligands.
- 19 November 2026
- Published by Wiley in British Journal of Pharmacology
Open AccessStructural characterisation of the effect of 5‐chloroindole on orthosteric activation of murine 5‐HT 3A receptors
Background and Purpose: 5‐HT 3 receptors play a central role in gut–brain signalling, and their hyperactivity is associated with pathologies ranging from chemotherapy‐induced nausea and vomiting to irritable bowel syndrome. While the principles governing 5‐HT 3 R orthosteric pharmacology are well established (spanning antagonists, partial agonists and full agonists), structural insights into allosteric mechanisms remain limited. This study aimed to investigate the mechanisms by which a positive modulator of 5‐HT 3 R, 5‐chloroindole, potentiates agonist response by fine‐tuning orthosteric activation of this receptor. Experimental Approach: Here, we investigated the molecular basis of modulation by 5‐chloroindole (5‐CI), a selective positive allosteric modulator, using cryo‐EM and electrophysiology. We present 5‐HT 3A R structures in the presence of 5‐CI alone, as well as in combination with either submaximal concentrations of 5‐HT or saturating concentrations of the partial agonist SMP‐100. Key Results: Our results reveal that 5‐CI potentiates 5‐HT 3 R through a distinct mechanism involving co‐occupancy of the orthosteric site and with additional modulation through an intersubunit site in the transmembrane domain. Conclusions and Implications: This mode of action is reminiscent of benzodiazepine modulation in GABA A Rs, yet it notably occurs within homomeric binding sites. Together, these findings establish the structural basis for the previously reported ago‐allosteric mechanism of 5‐CI, which becomes functionally apparent only in the presence of agonistic ligands.
- Open Access
State-specific binding thermodynamics predicts ligand efficacy across ion-channel families
Predicting ligand efficacy is a critical challenge in drug discovery, as a target’s functional response is often determined by the way a ligand shifts conformational equilibria between different functional states, a process that is particularly intricate in ion channels. We classify ligands based on the difference of their binding free energies on putative active and inactive conformations, calculated via free energy perturbation (FEP) for 78 protein-ligand pairs across six ion channels from four structural superfamilies: GluA2, GABA A R ρ1, α3β4 nAChR, 5-HT 3A R, TRPML1, and KCNQ2. This approach accurately distinguishes agonists from antagonists across all these ion-channel families with large or subtle structural differences, including at membrane-facing sites, and enables quantitative prediction of maximum response and partial agonism. Importantly, we find that local binding-pocket conformations encode the bound ligand’s efficacy even when global channel states are ambiguous. Our results demonstrate that state-specific binding thermodynamics provides a robust framework for leveraging ion channel structures of diverse conformational states to elucidate mechanisms of action and to advance ion-channel drug discovery beyond simple affinity measurements, enabling the identification of new chemical matter with desired functional attributes.
Open AccessState-specific binding thermodynamics predicts ligand efficacy across ion-channel families
Predicting ligand efficacy is a critical challenge in drug discovery, as a target’s functional response is often determined by the way a ligand shifts conformational equilibria between different functional states, a process that is particularly intricate in ion channels. We classify ligands based on the difference of their binding free energies on putative active and inactive conformations, calculated via free energy perturbation (FEP) for 78 protein-ligand pairs across six ion channels from four structural superfamilies: GluA2, GABA A R ρ1, α3β4 nAChR, 5-HT 3A R, TRPML1, and KCNQ2. This approach accurately distinguishes agonists from antagonists across all these ion-channel families with large or subtle structural differences, including at membrane-facing sites, and enables quantitative prediction of maximum response and partial agonism. Importantly, we find that local binding-pocket conformations encode the bound ligand’s efficacy even when global channel states are ambiguous. Our results demonstrate that state-specific binding thermodynamics provides a robust framework for leveraging ion channel structures of diverse conformational states to elucidate mechanisms of action and to advance ion-channel drug discovery beyond simple affinity measurements, enabling the identification of new chemical matter with desired functional attributes.
- Open Access
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eaeb2036
Structural basis for domain coupling in heteromeric glycine receptors revealed by an atypical allosteric agonist
Glycine receptors (GlyRs), pentameric ligand-gated ion channels (pLGICs), mediate sensory and motor functions. GlyR functional states are well characterized; however, structural details of transitions between states remain undefined. Here, we determined cryo–electron microscopy structures of GlyRα1β (with gephyrin E-domain) at varying concentrations of ivermectin, a transmembrane domain (TMD) allosteric agonist, and at saturating concentrations of strychnine, a competitive antagonist at the extracellular domain (ECD). Electrophysiology shows that ivermectin activates GlyR even with strychnine present. Structures with both ligands reveal intermediate states featuring a desensitized TMD and an ECD between closed and desensitized conformations, providing insights into domain cooperativity and ligand efficacy. Molecular dynamics simulations show how ivermectin affects strychnine dynamics. These data support a model where ivermectin activates GlyRs through a concerted and near-symmetric TMD mechanism, whereas allosteric ECD motions are graded and spatially heterogeneous. These findings reveal unanticipated features of GlyR gating and establish principles of allosteric modulation applicable to pLGICs.
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eaeb2036
Open AccessStructural basis for domain coupling in heteromeric glycine receptors revealed by an atypical allosteric agonist
Glycine receptors (GlyRs), pentameric ligand-gated ion channels (pLGICs), mediate sensory and motor functions. GlyR functional states are well characterized; however, structural details of transitions between states remain undefined. Here, we determined cryo–electron microscopy structures of GlyRα1β (with gephyrin E-domain) at varying concentrations of ivermectin, a transmembrane domain (TMD) allosteric agonist, and at saturating concentrations of strychnine, a competitive antagonist at the extracellular domain (ECD). Electrophysiology shows that ivermectin activates GlyR even with strychnine present. Structures with both ligands reveal intermediate states featuring a desensitized TMD and an ECD between closed and desensitized conformations, providing insights into domain cooperativity and ligand efficacy. Molecular dynamics simulations show how ivermectin affects strychnine dynamics. These data support a model where ivermectin activates GlyRs through a concerted and near-symmetric TMD mechanism, whereas allosteric ECD motions are graded and spatially heterogeneous. These findings reveal unanticipated features of GlyR gating and establish principles of allosteric modulation applicable to pLGICs.
- Open Access
- 5 January 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (1)
Structure and function of the RNA polymerase complex of Borna disease virus, a nuclear-replicating non-segmented negative-strand RNA virus
Borna disease virus 1 (BoDV-1) is a non-segmented negative-strand (NNS) RNA virus that uniquely replicates in the nucleus of mammalian host cells, in contrast to most NNS RNA viruses that replicate in the cytoplasm. The mechanisms underlying nuclear replication of BoDV-1 and related bornaviruses with their RNA-dependent RNA polymerase (RdRp) complexes remain poorly understood. Here, we report the 2.8 Å cryo-EM structure of the BoDV-1 RdRp complex, comprising the large (L) protein and tetrameric phosphoprotein (P). The L protein features an N-terminal superdomain containing the RdRp and GDP polyribonucleotidyltransferase (PRNTase, mRNA-capping enzyme) domains, along with three C-terminal appendages, including a methyltransferase-like domain. The RdRp initiates de novo RNA synthesis internally at the genomic promoter, producing 5′-triphosphorylated transcripts corresponding to the 5′ end of the anti-genome. P interacts with the fingers RdRp subdomain of L. Structure-guided mutagenesis shows that the residues involved in the L–P interaction are essential for efficient transcription initiation and, consequently, for viral gene expression. A flexible loop within the PRNTase domain, analogous to the rhabdovirus priming-capping loop, appears critical for transcription initiation. These findings provide the structural and functional insights into the BoDV-1 RdRp and support a shared evolutionary origin between nuclear and cytoplasmic NNS RNA viruses.
- 5 January 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (1)
Open AccessStructure and function of the RNA polymerase complex of Borna disease virus, a nuclear-replicating non-segmented negative-strand RNA virus
Borna disease virus 1 (BoDV-1) is a non-segmented negative-strand (NNS) RNA virus that uniquely replicates in the nucleus of mammalian host cells, in contrast to most NNS RNA viruses that replicate in the cytoplasm. The mechanisms underlying nuclear replication of BoDV-1 and related bornaviruses with their RNA-dependent RNA polymerase (RdRp) complexes remain poorly understood. Here, we report the 2.8 Å cryo-EM structure of the BoDV-1 RdRp complex, comprising the large (L) protein and tetrameric phosphoprotein (P). The L protein features an N-terminal superdomain containing the RdRp and GDP polyribonucleotidyltransferase (PRNTase, mRNA-capping enzyme) domains, along with three C-terminal appendages, including a methyltransferase-like domain. The RdRp initiates de novo RNA synthesis internally at the genomic promoter, producing 5′-triphosphorylated transcripts corresponding to the 5′ end of the anti-genome. P interacts with the fingers RdRp subdomain of L. Structure-guided mutagenesis shows that the residues involved in the L–P interaction are essential for efficient transcription initiation and, consequently, for viral gene expression. A flexible loop within the PRNTase domain, analogous to the rhabdovirus priming-capping loop, appears critical for transcription initiation. These findings provide the structural and functional insights into the BoDV-1 RdRp and support a shared evolutionary origin between nuclear and cytoplasmic NNS RNA viruses.
- Open Access
- 20 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (51) , eadr5920
Mechanisms underlying modulation of human GlyRα3 by Zn 2+ and pH
Glycine receptors (GlyRs) regulate motor control and pain processing in the central nervous system through inhibitory synaptic signaling. The subtype GlyRα3 expressed in nociceptive sensory neurons of the spinal dorsal horn is a key regulator of physiological pain perception. Disruption of spinal glycinergic inhibition is associated with chronic inflammatory pain states, making GlyRα3 an attractive target for pain treatment. GlyRα3 activity is modulated by numerous endogenous and exogenous ligands that consequently affect pain sensitization. To understand the mechanism of two such endogenous modulators, Zn 2+ and protons, we have used cryo–electron microscopy to determine structures of full-length human GlyRα3 in various functional states. Whereas acidic pH reduces peak glycine response, Zn 2+ displays biphasic modulation in a concentration-dependent manner. Our findings reveal the effector sites and also capture intermediate conformations in the gating cycle. Combined with molecular dynamics simulations and electrophysiology, this work provides important insights into GlyRα3 activation and regulation.
- 20 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (51) , eadr5920
Open AccessMechanisms underlying modulation of human GlyRα3 by Zn 2+ and pH
Glycine receptors (GlyRs) regulate motor control and pain processing in the central nervous system through inhibitory synaptic signaling. The subtype GlyRα3 expressed in nociceptive sensory neurons of the spinal dorsal horn is a key regulator of physiological pain perception. Disruption of spinal glycinergic inhibition is associated with chronic inflammatory pain states, making GlyRα3 an attractive target for pain treatment. GlyRα3 activity is modulated by numerous endogenous and exogenous ligands that consequently affect pain sensitization. To understand the mechanism of two such endogenous modulators, Zn 2+ and protons, we have used cryo–electron microscopy to determine structures of full-length human GlyRα3 in various functional states. Whereas acidic pH reduces peak glycine response, Zn 2+ displays biphasic modulation in a concentration-dependent manner. Our findings reveal the effector sites and also capture intermediate conformations in the gating cycle. Combined with molecular dynamics simulations and electrophysiology, this work provides important insights into GlyRα3 activation and regulation.
- Open Access
- 24 July 2024
- Published by Oxford University Press (OUP) in Microscopy and Microanalysis
- Vol. 30 (Supplement)
Structural Dynamics of Heteromeric Glycine Receptor Complex
Glycine Receptors (GlyRs) at the inhibitory synapses in the spinal cord and brainstem are key players in regulating motor control and pain processing. GlyRs assemble as either homopentamers of α subunits (α1−α4) or heteropentamers of α subunits in combination with β subunits. Post-synaptic GlyRs are an obligate heteromeric assembly of α and β subunits, and are associated with gephyrin, a synaptic scaffold protein. Using Cryo-EM and single particle analysis, my group has determined structures of α1β GlyR in the presence of various orthosteric and allosteric ligands that evoke agonistic and antagonistic responses. These structures provide a detailed view of ligand-receptor interactions and conformational changes associated with different functional states. Molecular dynamic simulations and functional studies validate the proposed mechanisms. Together, our results show distinct compositional and conformational properties of α1βGlyR and provide a framework for further study of this physiologically important channel [ 1].
- 24 July 2024
- Published by Oxford University Press (OUP) in Microscopy and Microanalysis
- Vol. 30 (Supplement)
Open AccessStructural Dynamics of Heteromeric Glycine Receptor Complex
Glycine Receptors (GlyRs) at the inhibitory synapses in the spinal cord and brainstem are key players in regulating motor control and pain processing. GlyRs assemble as either homopentamers of α subunits (α1−α4) or heteropentamers of α subunits in combination with β subunits. Post-synaptic GlyRs are an obligate heteromeric assembly of α and β subunits, and are associated with gephyrin, a synaptic scaffold protein. Using Cryo-EM and single particle analysis, my group has determined structures of α1β GlyR in the presence of various orthosteric and allosteric ligands that evoke agonistic and antagonistic responses. These structures provide a detailed view of ligand-receptor interactions and conformational changes associated with different functional states. Molecular dynamic simulations and functional studies validate the proposed mechanisms. Together, our results show distinct compositional and conformational properties of α1βGlyR and provide a framework for further study of this physiologically important channel [ 1].
- Open Access
- 5 April 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (4) , 728
Author Correction: Structural basis for partial agonism in 5-HT3A receptors
- 5 April 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (4) , 728
Open AccessAuthor Correction: Structural basis for partial agonism in 5-HT3A receptors
- 4 January 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (4) , 598-609
Structural basis for partial agonism in 5-HT3A receptors
Hyperactivity of serotonin 3 receptors (5-HT3R) underlies pathologies associated with irritable bowel syndrome and chemotherapy-induced nausea and vomiting. Setrons, a class of high-affinity competitive antagonists, are used in the treatment of these conditions. Although generally effective for chemotherapy-induced nausea and vomiting, the use of setrons for treating irritable bowel syndrome has been impaired by adverse side effects. Partial agonists are now being considered as an alternative strategy, with potentially less severe side effects than full antagonists. However, a structural understanding of how these ligands work is lacking. Here, we present high-resolution cryogenic electron microscopy structures of the mouse 5-HT3AR in complex with partial agonists (SMP-100 and ALB-148471) captured in pre-activated and open-like conformational states. Molecular dynamics simulations were used to assess the stability of drug-binding poses and interactions with the receptor over time. Together, these studies reveal mechanisms for the functional differences between orthosteric partial agonists, full agonists and antagonists of the 5-HT3AR.
- 4 January 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (4) , 598-609
Structural basis for partial agonism in 5-HT3A receptors
Hyperactivity of serotonin 3 receptors (5-HT3R) underlies pathologies associated with irritable bowel syndrome and chemotherapy-induced nausea and vomiting. Setrons, a class of high-affinity competitive antagonists, are used in the treatment of these conditions. Although generally effective for chemotherapy-induced nausea and vomiting, the use of setrons for treating irritable bowel syndrome has been impaired by adverse side effects. Partial agonists are now being considered as an alternative strategy, with potentially less severe side effects than full antagonists. However, a structural understanding of how these ligands work is lacking. Here, we present high-resolution cryogenic electron microscopy structures of the mouse 5-HT3AR in complex with partial agonists (SMP-100 and ALB-148471) captured in pre-activated and open-like conformational states. Molecular dynamics simulations were used to assess the stability of drug-binding poses and interactions with the receptor over time. Together, these studies reveal mechanisms for the functional differences between orthosteric partial agonists, full agonists and antagonists of the 5-HT3AR.
- Open Access
- 13 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
Glycine Receptors (GlyRs) provide inhibitory neuronal input in the spinal cord and brainstem, which is critical for muscle coordination and sensory perception. Synaptic GlyRs are a heteromeric assembly of α and β subunits. Here we present cryo-EM structures of full-length zebrafish α1βBGlyR in the presence of an antagonist (strychnine), agonist (glycine), or agonist with a positive allosteric modulator (glycine/ivermectin). Each structure shows a distinct pore conformation with varying degrees of asymmetry. Molecular dynamic simulations found the structures were in a closed (strychnine) and desensitized states (glycine and glycine/ivermectin). Ivermectin binds at all five interfaces, but in a distinct binding pose at the β-α interface. Subunit-specific features were sufficient to solve structures without a fiduciary marker and to confirm the 4α:1β stoichiometry recently observed. We also report features of the extracellular and intracellular domains. Together, our results show distinct compositional and conformational properties of α1βGlyR and provide a framework for further study of this physiologically important channel.
- 13 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessConformational transitions and allosteric modulation in a heteromeric glycine receptor
Glycine Receptors (GlyRs) provide inhibitory neuronal input in the spinal cord and brainstem, which is critical for muscle coordination and sensory perception. Synaptic GlyRs are a heteromeric assembly of α and β subunits. Here we present cryo-EM structures of full-length zebrafish α1βBGlyR in the presence of an antagonist (strychnine), agonist (glycine), or agonist with a positive allosteric modulator (glycine/ivermectin). Each structure shows a distinct pore conformation with varying degrees of asymmetry. Molecular dynamic simulations found the structures were in a closed (strychnine) and desensitized states (glycine and glycine/ivermectin). Ivermectin binds at all five interfaces, but in a distinct binding pose at the β-α interface. Subunit-specific features were sufficient to solve structures without a fiduciary marker and to confirm the 4α:1β stoichiometry recently observed. We also report features of the extracellular and intracellular domains. Together, our results show distinct compositional and conformational properties of α1βGlyR and provide a framework for further study of this physiologically important channel.